Piperine – Is a purified extract from the fruit of Black and Long Peppers (Piper nigrum and Piper longum), a generally recognized as safe (GRAS) lipophilic (‘fat soluble”) alkaloid that is responsible for pepper’s pungency (“spiciness”).
(Studies listed in the Scientific Studies)

Helps Support:
Increased Nutrient Absorption

It is a part of Ayurveda, the traditional medicine of India, dating back well over two thousand years ago, and one of its most widely used herbs in two-thirds of all Ayurvedic prescriptions. Together with the pungent alkaloids found in other spices like garlic, ginger, licorice and turmeric, it increases the bioavailabilty of coadministered substances such as vitamins, minerals, dietary supplements and pharmaceutics.

​Piperine acts as “bioenhancer” of various substances. Current published studies have shown that it significantly increases the absorption and bioavailabilty of vitamins (B1, B2, B3, B6, B9, B12, C), minerals (iodine, calcium, iron, zinc, copper, selenium, magnesium, potassium, manganese), amino acids (lysine, isoleucine, leucine, threonine, valine, tryptophan, phenylalanine, methionine), herbal compounds (curcumin, ginsenosides, quercetin, coenzyme Q10, resveratrol, epigallocatechin gallate from green tea, pycnogenol), and drugs (such as ibuprofen, diclofenac, rifampicin, ampicillin, tetracycline, pyrazinamide, fexofenadine). For example, it has been shown to increase curcumin levels by 2000%.

Drugs, supplements and nutrients taken by mouth (as opposed to intravenous, sublingual, intranasal, transdermal, buccal) are affected by “first pass metabolism.” Essentially, they are degraded by digestion in the stomach and intestines by acids and enzymes; significantly altered in the liver; and, excreted. This affects their bioavailabilty – the amount of the substance that actually ends up in circulation – in the blood.

For example, cannabidiol (CBD) is 34-46% bioavailable intranasally; 40% when vaporized; but, approximately 6-9% when taken orally: so, for every 100mg ingested, only 9mg is available for use. Orally, aspirin is 68%, Zolpidem (i.e. Ambien®) 67%, diphenhydramine (e.g. Benadryl®) 40-60%, ACE inhibitors (e.g. Benazepril/Lotensin®) 37% and statins (i.e. Simvastatin/Zocor®) only 5% capable of being used by the body.

The bioavailabilty of a substance is based on four different processes: (1) conversion: enzymes in the gut breakdown the substance into something much less active; (2) absorption: shuttling the substance to the intestines where they can be transferred to the blood thru the intestinal lining; (3) exclusion: removing substances from the cells that cannot be used; and, (4) solubility: adding to the substance to make it unable to enter the cells. Piperine has the ability to affect all of these processes.

Piperine inhibits the enzymes in the gut and intestines that breakdown/metabolize and convert drugs and nutritive substances. It stimulates the activity of amino-acid transporters in the intestinal lining. It inhibits p-glycoprotein, the ‘pump’ protein that removes substances from cells and it decreases the intestinal production of glucuronic acid, thereby permitting more of the substances to enter the body in active form. Consequently, some of these substances are able to reach, enter, and remain within their target cells for longer periods of time than would otherwise be the case. Therefore, Piperine can sometimes turn a marginally effective therapeutic substance into a highly effective one simply by increasing its bioavailability and intracellular residency.

  1. Ahmad, N, Fazal H, Abbasi B et al:  Khan, M.A. (2012) Biological Role of Piper nigrum L. (Black Pepper): A Review. Asian Pac J Trop Biomed, 2010, 5:1945-1953.

  2. Ajazuddin, Alexander A, Qureshi A et al: Role of herbal bioactives as a potential bioavailability enhancer for Active Pharmaceutical Ingredients. Fitoterapia. 2014 Sep;97C:1-14.

  3. Allameh A, Saxena M, Biswas G et al: Piperine, a plant alkaloid of the piper species, enhances the bioavailability of aflatoxin B1 in rat tissues. Cancer Lett. 1992 Jan 31;61(3):195-9.

  4. Alodeani E, Arshad M, Izhari M: Drug likeness and physicochemical properties evaluation of the alkaloids found in black pepper: piperine, piperidine, piperettine and piperanine. Eur J Pharm Med Res, 2015, 2(6), 296-301.

  5. Alvarez-Berdugo D, Jiménez M, Clavé P et al: Pharmacodynamics of TRPV1 Agonists in a Bioassay Using Human PC-3 Cells, Sci World J, 2014, ID 184526, 6 pages.

  6. Atal N, Bedi K: Bioenhancers: Revolutionary concept to market. J Ayur Integ Med 2010. 1:96–9.

  7. Atal C, Dubey R, Singh J: Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism.  J. Pharmacol. Exp. Ther. 1985. 232(1):258–62.

  8. Atal K, Zutshi U, Rao P: Scientific evidence on the role of Ayurvedic herbals on bioavailability of drugs. J Ethnopharm 1981. 4(2): 229-32.

  9. Badmaev V, Majeed M, Norkus E: Piperine, an alkaloid derived from black pepper increases serum response of beta-carotene during 14-days of oral beta-carotene supplementation. Nutri Res. 1999, 19(3): 381–388.

  10. Badmaev V, Majeed M, Prakash L: Piperine derived from black pepper increases the plasma levels of coenzyme Q10 following oral supplementation. J Nutri Biochem 2000; 11(2):109–113.

  11. 1.     Bajad S, Bedi K, Singla A et al: Piperine inhibits gastric emptying and gastrointestinal transit in rats and mice. Planta Medica 2001. 67: 176-179

  12. 2.     Bano G, Amla V, Raina R et al: The effect of piperine on pharmacokinetics of phenytoin in healthy volunteers. Planta Medica. 1987, 53(6): 568–569.

  13. 3.     Bano G, Raina R, Zutshi U et al: Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. Eur J Clin Pharmacol. 1991;41(6):615-7.

  14. Bedada S, Boga P, Kotakonda H: Study on influence of piperine treatment on the pharmacokinetics of diclofenac in healthy volunteers. Xenobiotica. 2017, 47(2):127-132.

  15. Bhardwaj K, Glaeser H, Becquemont L et al: Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharm Exp Ther. 2002, 302(2):645-650.

  16. Cai L, Liu J, Li L et al: [Effect of piperine on metabolism and distribution of nortriptyline in mice]. J Cent South Univ (Med Sci), 2014, 39(4): 349-54.

  17. Chopra B, Dhingra A, Kapoor R et al: Piperine and Its Various Physicochemical and Biological Aspects: A Review. Open Chem J, 2016, 3, 75-96.

  18. Dama M, Varshneya C, Dardi M et al: Effect of trikatu pretreatment on the pharmacokinetics of pefloxacin administered orally in mountain Gaddi goats. J Vet Sci. 2008 Mar;9(1):25-9.

  19. Desai S, Gawali V, Naik A et al: Potentiating effect of piperine on hepatoprotective activity of Boerhaaviadiffusa to combat oxidative stress. Int J Pharmacogn, 2008, 4:393-397.

  20. Di X, Wang X, Di X et al: Effect of piperine on the bioavailability and pharmacokinetics of emodin in rats. J Pharm Biomed Anal. 2015 Nov, 115:144-9.

  21. Dubey R, Leeners B, Imthurn B et al: Piperine Decreases Binding of Drugs to Human Plasma and Increases Uptake by Brain Microvascular Endothelial Cells. Phytother Res. 2017, 31(12):1868-1874.

  22. Dudhatra G, Mody S, Awale M et al: A Comprehensive Review on Pharmacotherapeutics of Herbal Bioenhancers. Sci World J. 2012, Sept: 637953.

  23. Feng X, Liu Y, Wang X et al: Effects of piperine on the intestinal permeability and pharmacokinetics of linarin in rats. Molecules. 2014 Apr 30;19(5):5624-33.

  24. Gopal V, Prakash G, Velvizhi T: Bio-Enhancer: A Pharmacognostic Perspective. Eur J Mol Biol Biochem. 2016;3(1):33-38.

  25. Gorgani, L, Mohammadi M, Najafpour G et al: d, M. (2017), Piperine—The Bioactive Compound of Black Pepper: From Isolation to Medicinal Formulations. Comp Rev Food Sci Food Safe 2017. 16:124–140.

  26. Gupta  P, Nagwansi D, Gupta S: Comparative standardization of a polyherbal ayurvedic formulation trikatu churna. J Chem Pharm Res, 2015. 7(12):191-196

  27. Hiwale A, Dhuley J, Naik S: Effect of co-administration of piperine on pharmacokinetics of f3-lactam antibiotics in rats. Ind J Exp Bio. 2002, 40:277-281.

  28. Janakiraman K, Manavalan R: Studies on Effect of Piperine on Oral Bioavailability of Ampicillin and Norfloxacin.  Afr J Trad Comp Alt Med. 2008; 5(3): 257–262.

  29. Jamwal D, Singh J: Effects of piperine on enzyme activities and bioenergetic functions in isolated rat liver mitochondria and hepatocytes. J Biochem Toxicol. 1993 Dec;8(4):167-74.

  30. Jhanwar J, Gupta S: Biopotentiation using Herbs: Novel Technique for Poor Bioavailable Drugs. Int J PharmT Res 2014. 6(2): 443-454.

  31. Jin, M, Han, H: Effect of Piperine, a Major Component of Black Pepper, on the Intestinal Absorption of Fexofenadine and Its Implication on Food–Drug Interaction. J Food Sci., 2010. 75: H93–H96.

  32. Johnson J, Nihal M, Siddiqui I et al: Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutri Food Res. 2011, 55(8): 1169–1176.

  33. Johri R, Thusu N, Khajuria A et al: Piperine mediated changes in the permeability of rat intestinal epithelial cells. The status of γ-glutamyl transpeptidase activity, uptake of amino acids and lipid peroxidation. Biochem Pharm. 1992, 43(7):1401-7.

  34. Kang M, Cho J, Shim B et al: Bioavailability enhancing activities of natural compounds from medicinal plants. J Med Plant Res. 2009, 3(13): 1204–1211.

  35.    Kasibhatta R, Naidu M: Influence of piperine on the pharmacokinetics of nevirapine under fasting conditions: a randomised, crossover, placebo-controlled study. Drugs R D. 2007;8(6):383-91.

  36. Karan R, Bhargava V, Garg S: Effect of trikatu, an ayurvedic prescription, on the Pharmacokinetic profile of carbamazepine in rabbits. Indian J Physiol Pharmacol 1999; 43 (1): 133-136

  37. Kesarwani K, Gupta R, Mukerjee A: Bioavailability enhancers of herbal origin: an overview. Asian Pac J Trop Biomed. 2013 Apr; 3(4):253-66.

  38. Khajuria A, Thusu N, Zutshi U: Piperine modulates permeability characteristics of intestine by inducing alterations in membrane dynamics: influence on brush border membrane fluidity, ultrastructure and enzyme kinetics. Phytomedicine. 2002 Apr;9(3):224-31.

  39. Khajuria A, Zutshi U, Bedi K: Permeability characteristics of piperine on oral absorption–an active alkaloid from peppers and a bioavailability enhancer. Indian J Exp Biol. 1998 Jan;36(1):46-50.

  40. Khan I, Mirza Z, Kumar A et al: Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus. Antimicrob Agents Chemo. 2006 Feb;50(2):810-2.

  41. Khan Z, Moni F, Sharmin S et al: Isolation of Bulk Amount of Piperine as Active Pharmaceutical Ingredient (API) from Black Pepper and White Pepper (Piper nigrum L.). Pharmacol Pharm, 2017, 8, 253-262.

  42. Kulkarni A, Dias R: Natural products as bioavailability enhancers. Int J Inv Pharm Sci Res 2017. 5(12):24-33.

  43. Kumar S, Dobos G, Rampp T: The Significance of Ayurvedic Medicinal Plants.  J Evid Base Int Med, 2017. (22)3:494-501

  44. Lambert J, Hong J, Kim D et al: Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice.  J Nutrition. 2004. 134(8); 1948-52.

  45. Lee S, Kim H, Back S et al: Piperine-mediated drug interactions and formulation strategy for piperine: recent advances and future perspectives. Expert Opin Drug Metab Toxicol. 2018 Jan;14(1):43-57.

  46. Liang Y, Chen H, Su Z et al: White Pepper and Piperine Have Different Effects on Pharmacokinetics of Puerarin in Rats. Evid Based Comp Alt Med 2014.

  47. Majeed M, Badmaev V, Rajendran R, Inventors; Sabinsa Corporation, assignee. Use of piperine to increase the bioavailability of nutritional compounds.  US patent 5,536,506, Jul. 16, 1996.

  48. Majeed M, Badmaev V, Rajendran R, Inventors; Sabinsa Corporation, assignee. Use of piperine as a bioavailability enhancer. US patent 5,744,161. April 28, 1998.

  49. Majeed M, Badmaev V, Rajendran R, Inventors; Sabinsa Corporation, assignee. Use of piperine as a bioavailability enhancer. US patent 5,972,382. October 26, 1999.

  50. Makhov P, Golovine K, Canter D et al: Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity. Prostate. 2012 May 1;72(6):661-7.

  51. Mann A: Biopotency role of culinary spices and herbs and their chemical constituents in health and commonly used spices in Nigerian dishes and snacks. African J Food Sci, 2011, 5: 111-124.

  52. Meghwal M, Goswami T: Piper nigrum and Piperine: An Update. Phyto Res 2013. 27(8): 1121–1130.

  53. Mujumdar A, Dhuley J, Deshmukh V et al: Effect of piperine on pentobarbitore induced hypnosis in rats. Indian J Exp Biol, 1990a, 28:486-487.

  54. Muneer C, Pandey V: Effect of Piperine on Oral Bioavailability of Diltiazem HCl in Rabbits. Int J Pharm App. 2012, 3(4):406-413.

  55. Panahi Y, Badeli R, Karami G et al: Investigation of the Efficacy of Adjunctive Therapy with Bioavailability-Boosted Curcuminoids in Major Depressive Disorder. Phytother Res. 2015, 29(1):17-21.

  56. Panahi Y, Ghanei M, Hajhashemi A et al: Effects of Curcuminoids-Piperine Combination on Systemic Oxidative Stress, Clinical Symptoms and Quality of Life in Subjects with Chronic Pulmonary Complications Due to Sulfur Mustard: A Randomized Controlled Trial. J Diet Suppl. 2016;13(1):93-105.

  57. Parmar V, Jain S, Bisht K et al: Phytochemistry of genus piper. Phytochemistry 1997. 46:597-673.

  58. Park T, Jeong N, Inventors; Industry-Academic Cooperation Foundation, assignee.  Piperine derivatives and uses thereof.  US patent 9,321,751. April 26, 2016.

  59. Patel R, Modi I, Inventors; Cadila Laboratories Limited, assignee. Compositions containing piperine.  US patent 5,616,593. April 1, 1997.

  60. Pattanaik S, Hota D, Prabhakar S et al: Pharmacokinetic interaction of single dose of piperine with steady-state carbamazepine in epilepsy patients. Phytotherapy Res. 2009, 23(9): 1281–1286.

  61. Rahimnia A, Panahi Y, Alishiri G et al: Impact of Supplementation with Curcuminoids on Systemic Inflammation in Patients with Knee Osteoarthritis: Findings from a Randomized Double-Blind Placebo-Controlled Trial. Drug Res (Stuttg). 2014 Jul 22. [Epub ahead of print]

  62. Randhawa G, Kullar J, Rajkumar:  Bioenhancers from mother nature and their applicability in modern medicine. Int J Appl Basic Med Res. 2011 Jan;1(1):5-10.

  63. Reanmongkol W, Janthasoot W, Wattanatorn W et al: Effects of piperine on bioenergetic functions of isolated rat liver mitochondria. Biochem Pharmacol. 1988 Feb 15;37(4):753-7.

  64. Reen R, Jamwal S, Taneja S et al: Impairment of UDP-glucose dehydrogenase and glucuronidation activities in liver and small intestine of rat and guinea pig in vitro by piperine. Biochem Pharm 1993. 46(2), 229-238.

  65. Reen R, Roesch S, Kiefer F et al: Piperine impairs cytochrome P4501A1 activity by direct interaction with the enzyme and not by down regulation of CYP1A1 gene expression in the rat hepatoma 5L cell line. Biochem Biophys Res Commun 1996. 218(2):562-9.

  66. Samy R, Pushparaj P,  Gopalakrishnakone P: A compilation of bioactive compounds from Ayurveda. Bioinformation 2008; 3:100-110.

  67. Schatman M: Medical Marijuana: The State of the Science. 2015, Feb. Medscape.

  68. Shanmugam S: Natural Bioenhancers: Current Outlook. Clin Pharmacol Biopharm 2015, 4:2

  69. Shoba G, Joy D, Joseph T et al: Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica, 1998. 64(4): 353–356.

  70. Singh A, Duggal S: Piperine- Review of Advances in Pharmacology. Int J Pharm Sci Nanotechnol. 2009. 2:615–20.

  71. Singh V, Maurya J, Mishra A et al: Review article: Fast Dissolving Tablet with Piperine. Am. J. PharmTech Res. 2013; 3(6):15-37.

  72. Singh V, Maurya J, Mishra A et al: Formulation and Evaluation of Mouth Dissolving Tablet of Norfloxacin with Piperine and their Antibacterial Activity. Am. J. PharmTech Res. 2013; 3(5):453-63.

  73. Singh A, Pawar V, Jakhmola V et al: In vivo assessment of enhanced bioavailability of metronidazole with piperine in rabbits. Res J Pharm Bio Chem Sci. 2010, 1(4):273–278.

  74. Singh V, Singh P, Mishra A et al: Piperine: delightful surprise to the biological world, made by plant “pepper” and a great bioavailability enhancer for our drugs and supplements. World J Pharm Res 2014: 3(6): 2084-2098.

  75. Singh S, Tripathi J, Rai N: An appraisal of the bioavailability enhancers in Ayurveda in the light of recent pharmacological advances. Ayu 2016. 37(1):3-10

  76. Srinivasan K: Black pepper and its pungent principle-piperine: A review of diverse physiological effects. Critical Reviews in Food Science and Nutrition. 2007. 47(8):735–48.

  77. Srinivasan K. (2013) Biological Activities of Pepper Alkaloids. In: Ramawat K., Mérillon JM. (eds) Natural Products. Springer, Berlin, Heidelberg.

  78. Tatiraju D, Bagade V, Karambelkar P et al: Natural Bioenhancers: An overview. J Pharm Phyto 2013; 2 (3): 55-60.

  79. Velpandian T, Jasuja R, Bhardwaj R: Piperine in food: Interference in the pharmacokinetics of phenytoin.  Eur J Drug Met Kin, 2001, 26:241-247.

  80. Venkatesh S, Durga K, Padmavathi Y et al: Influence of piperine on ibuprofen induced antinociception and its pharmacokinetics. Drug Res, 2011; 61:506–509.

  81. Volak LP, Hanley MJ, Masse G et al: Effect of a herbal extract containing curcumin and Piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers. Br J Clin Pharmacol. 2013 Feb;75(2):450-62.

  82. Wadhwa S, Singhal S, Rawat S: Bioavailability Enhancement by Piperine: A Review. Asian J Biomed Pharma Sci. 2014, 04(36): 1-8.

  83. Wightman E, Reay J, Haskell C et al: Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in human subjects: a randomised, double-blind, placebo-controlled, cross-over investigation. Br J Nutr. 2014 Jul;112(2):203-13.

  84. Yang J, Mao K, Huang P et al: Effect of piperine on the bioavailability and pharmacokinetics of rosmarinic acid in rat plasma using UPLC-MS/MS. Xenobiotica. 2018 Feb; 48(2):178-185

  85. Zaveri M, Patel A, Khandhar A et al: Chemistry and Pharmacology of Piper Longum L. Int J Pharm Sci Rev Res. 2010, Dec; 5(1):67-76.

  86. Zutshi U, Kaul J: The impact of Ayurvedic herbals on drug bioavailability. Indian Drugs, 1982, 19:476–479.

  87. Zutshi U: “A process for the preparation of pharmaceutical combination with enhanced activity for treatment of tuberculosis and leprosy,” Indian Patent No. 1232/DEL/89, 1989.